Back to search

France· FR:66576865

EXACOR 130 mg, comprimé pelliculé sécable

A cibenzoline product containing succinate de cibenzoline, registered in France by LABORATOIRE XO, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C01BG07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedEXACOR 130 mg, comprimé pelliculé séc…ATCC01BG07REGISTER NO.FR:66576865PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Cibenzoline is registered in 3 of 19 countries.

Countries holding a registration under ATC C01BG07 (cibenzoline), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 2 of them publish a price we can compare per daily dose

Cibenzoline · ATC C01BG07

3 / 19 countries

  • Belgiumprice
  • Franceprice
  • Japan
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SUCCINATE DE CIBENZOLINE
Manufacturer
LABORATOIRE XO
Country
France (FR)
ATC code
C01BG07
ATC class
Cibenzoline
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400933450243
    plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)
    EUR 11.92

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cibenzoline in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cibenzoline products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e1617238-25aa-404f-a385-dc094703e990
GET /v1/drugs/e1617238-25aa-404f-a385-dc094703e990?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66576865",
  "date_amm": "1991-12-30",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SUCCINATE DE CIBENZOLINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about cibenzoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.